Li 1996.

Methods	RCT Method of random allocation: not described. Masking: states single‐blinded but unclear who is blinded patients, healthcare providers or healthcare assessors. Description of withdrawals and dropouts: numbers and reasons clearly stated; total ‐ 4 (died ‐ 3; transplant ‐ 1) Analysis on intention to treat basis: unclear Duration of follow‐up: 12 months
Participants	40 new ESRD patients in single unit. 20 in treatment group and 20 in control group. Male:female ratio: treatment group ‐ 9:11; control group ‐ 6:14. Age (mean,SD): treatment group ‐ 50(8) years; control group 47(15) years. Co‐morbidity: treatment group ‐ diabetes (5); HBsAg carriers (2); control group ‐ diabetes (4); HBsAg carriers (3).
Interventions	Y‐set (Ultraset, Baxter) with drain/flush/fill (treatment) vs conventional spike (control). 3 exchanges per day.
Outcomes	Peritonitis Exit site infections Hospitalisation Duration of training Mortality
Notes
Risk of bias
Bias	Authors' judgement	Support for judgement
Allocation concealment (selection bias)	Unclear risk	B ‐ Unclear